May 13, 2026 First-In-Human Trial Shows Success: CRISPR-Edited Hematopoietic Cells + Gemtuzumab Ozogamicin Achieve Full Engraftment
April 24, 2026 Everolimus Shows Promise in Biomarker-Guided Trial for Diffuse Intrinsic Pontine Glioma Despite Primary Endpoint Not Being Met
February 5, 2026 Targeted Cancer Therapies: Improved Outcomes & Survival Rates | Blood Cancer Treatment
